Photo of Andrea Necchi from unisr.it
Jun 3, 2024, 06:39
Andrea Necchi: MTAP loss be a potentially novel synthetic lethality target in 24% urothelial cancers
Andrea Necchi, Associate Professor at Vita-Salute San Raffaele University, shared on X/Twitter:
“By analyzing 540K pantumor samples we highlighted MTAP loss be a potentially novel synthetic lethality target in 24% urothelial cancers. Definitely worth considering for the next trial designs | Huge congrats to my team and the unique Jeff Ross.”
Source: Andrea Necchi/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 13:05
Dec 21, 2024, 12:18
Dec 21, 2024, 11:52
Dec 21, 2024, 11:30
Dec 21, 2024, 11:25